ArticleFrontiers in oncology2023

Development and validation of nomograms for predicting survival outcomes in patients with T1-2N1 breast cancer to identify those who could not benefit from postmastectomy radiotherapy.

Hongyu Pu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.